Skip to main content
Premium Trial:

Request an Annual Quote

Harry Stylli, Stephen David, Volker Muschalek, Michael Murphy, and Christine Seidman

Premium

Harry Stylli has been appointed the new President and CEO of Sequenom, the company said this week. Stylli most recently served as President and CEO of Xencor, where he is still a member of the board of directors. He earned a PhD from the London University's Faculty of Medicine, and an MA in business administration from the UK's Open University.


Stephen David has joined Nonlinear Dynamics' strategic marketing team, the Newcastle upon Tyne, UK-based company said this week. He comes to Nonlinear from GE Healthcare, formerly Amersham Biosciences, where he worked as DiGE global applications specialist.


Volker Muschalek has left MWG Biotech, effective May 31, the company said this week. He was one of two members of the company's management board and in charge of operations, human resources, IT, and the company's India business.


Michael Murphy has become senior vice president of operations of Pacific Biometrics, the company said this week. He joins the Pacific from LabCorp, where he was a technical director. Murphy holds a doctorate in pathology and physiological chemistry from Ohio State University and a BS in natural sciences from Xavier University in Cincinnati.


Christine Seidman has been elected to the National Academy of Sciences, the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics said last week. She is an associate director of HPCGG; director of the cardiovascular genetics service at the Brigham and Women's Hospital in Boston; and a Howard Hughes investigator.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.